Shows
340B UnscriptedEp 79 | 340B Rebate Model UpdateIn this episode, Greg and Rob share initial reactions to the HRSA update on 340B rebate model implementation. They’ll review the communication provided by HRSA on October 30th on their website, as well as discuss some of the manufacturer letters published on October 31st, that formally communicate rebate policies to 340B stakeholders.
HRSA 340B Rebate Website: https://www.hrsa.gov/opa/340b-model-pilot-program
Beacon Manufacturer Resources Website (includes letters): https://cm.beaconchannelmanagement.com/pages/resources
Email us at 340BUnscripted@spendmend.com with questions, comments and topic suggestions!
2025-11-0352 min340B UnscriptedEp 78 | Government Shutdown, Most Favored Nations Pricing and Direct-to-Consumer Pharmacy Supply Chain DiscussionIn this episode, Greg and Rob chat about what the government shutdown might mean for 340B Program oversight in the short-term. They’ll also discuss a flurry of developments from manufacturers recently. Specifically, they’ll highlight efforts to promote more direct-to-consumer (DTC) pathways for obtaining medications, all related to a recent Trump Administration executive order calling for “most favored nation (MFN)” pricing for drugs in the U.S.
SpendMend will be at the 340B Grantee Conference in Atlanta October 20 – 22. Stop by our booth and also catch our presentation at the “Ask the Experts – Open Forum” while you are there!
2025-10-1333 min340B UnscriptedEp 77 | DSH Hospital ThreatsIn this episode, Greg and Rob are joined by SpendMend colleague Heather Lynch, to talk about how H.R.1 (i.e. One Big Beautiful Bill Act, or OBBBA) could impact 340B covered entities in the long run. They’ll discuss how federal Medicaid cuts projected from the bill could influence a trend in lower average DSH% for some hospitals, threatening 340B Program eligibility. They’ll also have a conversation about things hospitals should consider, both in the short term and long term, to brace for the impact.
In the intro, they’ll also catch up on various manufa...
2025-09-2950 min340B UnscriptedEp 76 | HRSA DRL Updates & 340B Rebate CommentsIn this episode, Greg and Rob review recent changes made to the HRSA Audit Data Request List (DRL). They also discuss some of the comments provided by the public to HRSA regarding potential 340B rebate models, debate a recent change to a manufacturer’s contract pharmacy restrictions, and highlight some communication that has gone out to hospitals regarding a proposed CMS 340B drug acquisition cost survey expected in CY26.
SpendMend’s comments on HRSA’s proposed 340B rebate model: https://www.regulations.gov/comment/HRSA-2025-0001-1115
CMS proposed Medicare Part B 340B drug acquisition cost su...
2025-09-151h 01340B UnscriptedEp 75 | 340B Rebate Guidance Update – HRSA FAQsIn this episode, Greg and Rob catch up on insights gathered and lessons learned from various forums our team has attended over the last few weeks. Also, they discuss the recently posted FAQ page provided by HRSA in response to questions around the 340B Rebate Model Pilot Program.
340B Rebate HRSA FAQ: https://www.hrsa.gov/opa/340b-model-pilot-program
340B Rebate Comments: https://www.regulations.gov/document/HRSA-2025-0001-0001
2025-09-0150 min340B UnscriptedEp 74 | Annual Hospital Recertification & Proposed Changes to OPAISIn this episode, Greg and Rob discuss tips for completing the annual 340B hospital recertification process, which is occurring now through early September. They also recap a recent notice in the Federal Register that signals HRSA’s intent on modifying some elements of OPAIS and the 340B enrollment/registration/recertification process. The guys also can’t help themselves and wrap up with another debate around impending 340B rebate considerations.
Proposed OPAIS changes: https://www.federalregister.gov/documents/2025/08/07/2025-14955/agency-information-collection-activities-proposed-collection-public-comment-request-information
Register for our Trulla webinar on August 26th: https://attendee.gotowebinar.com/register/2844398547415085144?source=340B+Uns...
2025-08-1830 min340B UnscriptedEp 73 | Coalition Recap & 340B Rebate Guidance ReleaseIn this episode, Greg and Rob share initial thoughts on 340B Rebate Model Guidance released by HRSA on July 31st. They also catch up on some of the hot topics that were generating conversations at the recent 340B Coalition Summer Conference Meeting.
2025-08-1143 min340B UnscriptedEp 72 | Insulin & EpiPen 340B Policy Changes for FQHCsThis week’s episode is a short one but a good one. Rob is out on vacation, so Greg is joined by SpendMend colleague Sabrina Allen to discuss the recent policy changes impacting FQHCs related to a Trump Administration executive order from earlier this year that address insulin and injectable epinephrine 340B pricing provisions.
SpendMend is at Booth #413 this week at the 340B Coalition Summer Conference in National Harbor, MD. Come meet our team, eat some chocolate and discuss what’s happening in the 340B world.
Webinar Alert! Join us for a webinar on 340B Pati...
2025-07-2120 min340B UnscriptedEp 71 | 2025 Midyear 340B Review – Conversation with Ted SlafskyIn this episode, Greg and Rob welcome back Ted Slafsky to recap what the first six months of 2025 have brought to the 340B landscape. They’ll talk about where we are at with 340B rebate model action, discuss how federal agency reorganization efforts could impact 340B regulatory oversight, recap state legislative wins for 340B providers and debate how Congress may address the call for 340B Program reform later in the year.
Come catch us at Booth #413 at the 2025 340B Coalition Summer Conference!
Listeners are welcome to use code “SpendMend25” to receive a 25% discount for new subscr...
2025-06-301h 00340B UnscriptedEp 70 | 340B Updates – IRA Guidance and Rebate ModelsIn this episode, Greg and Rob catch up on developments in the 340B space. They chat about new information provided by CMS for pharmacies related to the Medicare Drug Price Negotiation Program (some helpful links are below). Also, they debate about what might be coming with the widely anticipated 340B rebate model guidance.
CMS Medicare Transaction Facilitator (MTF) User Guide: https://www.cms.gov/files/document/negotiation-program-mtf-user-guide.pdf
CMS MTF Pharmacy FAQs: https://340breport.com/wp-content/uploads/2025/06/pharmacy-and-dispensing-entity-mtf-faq.pdf
2025-06-1632 min340B UnscriptedEp 69 | Quick 340B UpdateThis week's episode is a quick one. We pushed out this episode expecting to have HRSA guidance on rebate models to discuss, but we'll have to wait for that topic another day! Greg and Rob catch up on a few developments in the 340B news cycle, primarily recapping HRSA's first final agency action taken in the context of 340B ADR claims.
2025-06-0224 min340B UnscriptedEp 68 | 340B Hot Topics DiscussionIn this episode, Greg and Rob are joined by guest Peggy Tighe, healthcare attorney and government relations specialist. They catch up on lots of contemporary issues impacting 340B providers, including state legislative activity (19:44), the recent Trump Administration’s executive order on drug pricing (30:02), Senator Cassidy’s 340B investigation report (43:20), and movement in 340B rebate litigation (52:00). Also, listen for Dave Chappelle and magic mushroom references – this one was a lively discussion!
Register for our upcoming Trulla Webinar: https://attendee.gotowebinar.com/register/7502684065481252181?source=340B+Unscripted
Attending the 340B Grantees Spring Conference in Kansas City May 27 - 30? Come sa...
2025-05-121h 11340B UnscriptedEp 67 | 340B Location Issues – Webinar Follow UpIn this week’s episode, Greg and Rob are joined by colleague Heidi Larson to recap lots of questions that came out of a recent SpendMend webinar focused on 340B location issues. They’ll address issues like what is considered onsite vs. offsite for the purposes of OPAIS registration, when newly registered locations are eligible to use 340B and a variety of other issues pertaining to how entities need to address their locations from a 340B compliance perspective.
In the intro, the guys catch up on 340B hot topics in the news. They’ll hit highlights of lots o...
2025-04-211h 09340B UnscriptedEp 66 | OPAIS Database Compliance TipsIn this episode, Rob and Greg review tips and tricks for maintaining a covered entity’s registration on the OPAIS database. Failure to keep an up-to-date and accurate listing on OPAIS can result in audit findings, and may warrant a corrective action plan with HRSA. The guys will cover some of the common compliance pitfalls with keeping an accurate record on this website. Megan from the team chimes in, too, with some tips for grantee covered entities.
Register for our webinar to get CE for pharmacists and technicians: https://attendee.gotowebinar.com/register/7740801999245853530?source=340B+Unscripted
2025-04-071h 17340B UnscriptedEp 65 | IRA Impact on 340BIn this episode, Greg and Rob are joined by Meetali Desai, a pharmacy business leader for a large health system in New England, to discuss thoughts around projecting the impact that IRA-mandated Medicare drug prices will have on 340B covered entities, which will go into effect in January 2026. Meetali shares her approach to quantifying the impact a 340B provider might feel from the intersection between these two federal programs. She’ll also offer her insights into other hot topics in the 340B space. In the intro, the guys will discuss updates in the news, including movement in current litigation be...
2025-03-241h 01340B UnscriptedEp 64 | 340B Winter Coalition Conference RecapIn this week’s episode, Greg and Rob recap lessons learned from the recent 340B Coalition Winter Conference in San Diego. They’ll share commentary that was circulating regarding HRSA audit trends, 340B rebate models, Inflation Reduction Act impact on budgets, contract pharmacy developments and some insights on what to watch for out of Washington D.C.
Email us your questions at 340BUnscripted@spendmend.com!
2025-03-1043 min340B UnscriptedEp 63 | Provider-Based Rules & 340BOn this episode, Rob and Greg are joined again by healthcare attorney Emily Cook. Emily shares some insight into CMS Provider Based Rules and how 340B covered entities need to be thoughtful about where these rules intersect with various 340B Program initiatives, including new outpatient service implementation, referral capture and pharmacist-driven medication management models.
We are at 340B Coalition Winter Conference in San Diego, CA. Come visit us at booth #315 to talk with our team about hot topics in the 340B world, from patient definition to HRSA audits, to program optimization!
2025-02-241h 00340B UnscriptedEp 62 | Updates from Ongoing 340B LitigationIn this episode, Greg and Rob are joined again by Jeff Davis, healthcare attorney, to catch up on various court action impacting the 340B community. With so many 340B Program elements hung up in litigation, it's challenge to keep tabs on what has been happening. Jeff will recap key appellate court decisions on manufacturer-implemented restrictions of contract pharmacies, discuss the merits of litigation challenging state legislative efforts to protect contract pharmacy provisions, and share opinions on where 340B rebate models may go in the future. They'll also dive in to child site eligibility timing, HRSA-approved manufacturer, audits and recent...
2025-02-101h 07340B UnscriptedEp 61 | What Else is Happening in 340B to Start 2025In this week’s episode, Greg and Rob catch up on newsworthy developments in the 340B community. They’ll discuss various state and federal legislative developments, they’ll share how recent White House executive orders, including a pause on federal agency communications and grant funding freezes, may be impacting 340B providers, and they’ll offer some commentary on HHS Secretary confirmation hearing debate.
Catch us at the 340B Coalition Winter Conference in San Diego, CA! The SpendMend team will be at Booth 315
2025-02-0334 min340B UnscriptedEp 60 | What’s Happening in 340B to Start 2025In our first episode of 2025, Greg and Rob discuss the latest developments in 340B. They’ll recap HRSA audit trends, discuss how Congressional committee membership seems to be forming, and discuss a variety of 340B provisions being litigated in court.
2025-01-1548 min340B UnscriptedEp 59 | Recap of 340B Developments in 2024In our last episode of 2024, Greg and Rob recap major developments in the 340B space from the last year. They’ll start with trends in HRSA audit activity, including thoughts on patient definition. They’ll address a variety of manufacturer developments, from contract pharmacy restrictions to manufacturer audits to proposed 340B rebate models. They end with a forecast of what to watch for in 2025
Thank you for listening to our podcast! Email us at 340BUnscripted@spendmend.com if you have any questions or topics that you want us to address!
2024-12-171h 02340B UnscriptedEp 58 | Sanofi 340B Credit ModelIn this week’s episode, Greg and Rob cover the recent policy notice put out by Sanofi regarding a 340B credit model. They discuss how it compares to other proposed credit/rebate models, and more importantly how this one is unique.
In the intro, the guys recap developments in Washington D.C., as well as some updates in court action amongst HRSA, covered entities and manufacturers regarding audit activity.
2024-12-0251 min340B UnscriptedEp 57 | Post-Election Outcome & 340B ImplicationsIn this episode, Greg and Rob are joined by Rodney Whitlock, healthcare policy expert, to discuss the recent 2024 election results. They’ll discuss what the second Trump Administration might prioritize in terms of healthcare policy, how a Republican-controlled Congress will impact 340B legislation activity, and whether or not any developments coming out of the upcoming lame-duck session might be on the horizon for 340B providers.
In the intro, Greg and Rob catch up on a variety of topics, including J&J’s recently filed lawsuit against HRSA regarding rebate models, CMS final rules around inflation rebate penalties, and th...
2024-11-1454 min340B UnscriptedEp 56 | 2024 General Election Outlook & 340BIn this episode, Greg and Rob are joined by Mike Strazzella, government affairs expert from Buchanan Ingersoll & Rooney, to discuss the upcoming general election, and what races may be critical to future 340B policy developments. They’ll discuss Senate and House races that could precipitate leadership changes in Congressional committees that drive legislative work, debate what a future Harris or Trump administration means for health care policy in general, and they wrap up with some conversation around how stakeholders can successfully advocate for the importance of the 340B Program.
Have a 340B question or topic you want us...
2024-10-2855 min340B UnscriptedEp 55 | All About 340B ModifiersIn this episode, Greg and Rob discuss the various uses of 340B billing modifiers. They’ll discuss some general considerations around what billing modifiers are used for, highlight differences between hospital/clinic and pharmacy billing in terms of applying correct modifiers, and debate different aspects of Medicaid and Medicare billing modifier requirements. It’s another heavy duty 340B-operations focused episode.
2024-10-1458 min340B UnscriptedEp 54 | 340B Operations Discussion – “Clean Site” LocationsIn this episode, Greg and Rob get back to 340B basics and have a conversation around the concept of “clean site” 340B-only locations. They discuss what “clean site” means in the world of 340B, what the benefits of the approach are, what some of the risks and obstacles are from a compliance perspective, and share some anecdotes from past experiences working with these types of 340B universes.
In the intro, the guys discuss a couple of recent developments – most notably, J&J's response to HRSA's enforcement letter regarding the proposed rebate model.
Register for our upco...
2024-10-0150 min340B UnscriptedEp 54 | 340B Operations Discussion – “Clean Site” LocationsIn this episode, Greg and Rob get back to 340B basics and have a conversation around the concept of “clean site” 340B-only locations. They discuss what “clean site” means in the world of 340B, what the benefits of the approach are, what some of the risks and obstacles are from a compliance perspective, and share some anecdotes from past experiences working with these types of 340B universes.
In the intro, the guys discuss a couple of recent developments – CMS’s publication of the Medicaid Drug Rebate Program rule change and a revised Sanofi contract pharmacy policy impacting Arkansas cov...
2024-09-3046 min340B UnscriptedEp 53 | J&J 340B Rebate Model Follow-Up DiscussionIn this episode, Greg and Rob catch up on developments surrounding the J&J 340B rebate proposal, including HRSA’s response. They’ll address some outstanding questions from the recent SpendMend webinar on the topic.
In the intro, they recap some updates regarding contract pharmacy litigation and thoughts on how DSCSA and product serialization data might impact 340B operations.
If you missed it before, you can watch our webinar on the J&J 340B rebate model here: https://ww2.spendmend.com/webinar-jj-340b-rebate-model-what-covered-entities-need-to-know/
2024-09-2352 min340B UnscriptedEp 52 | 340B Smorgasbord - Contract Pharmacy Legislation, ADR, Section 1115 Waiver Days & 340B Rebate ModelsIn this episode, Greg and Rob are joined by healthcare attorney and 340B veteran Barbara Straub Williams. They cover a variety of topics, including an update on litigation targeting state-level contract pharmacy laws (21:18), navigating manufacturer audits and ADR claim submissions (38:47), a recent court ruling related to exclusion of Section 1115 wavier days from DSH percentage calculations (50:53), and last but not least a recent policy notice by J&J to covered entities announcing a 340B rebate model for two of their products (58:17).
In the intro, the guys offer some preliminary thoughts on the topics at hand this wee...
2024-09-031h 15340B UnscriptedEp 51 | CMS Medicaid Drug Rebate Program & “Covered Outpatient Drug” DefinitionIn this episode, Greg and Rob are joined by healthcare attorney Todd Nova to discuss a proposed rule change put forth by CMS in 2023 regarding the Medicaid Drug Rebate Program (MDRP), which includes a potential change to the definition of “covered outpatient drug”. They’ll discuss how covered entities have historically interpreted the definition of covered outpatient drugs, and what impact might come from CMS’s proposed change in this definition. Greg and Rob also get Todd’s take on recent HRSA audit activity in a post-Genesis 340B environment.
In the intro, the guys discuss the recent announceme...
2024-08-211h 17340B UnscriptedEp 50 | 340B Q&A with HoopiiThis is our 50th episode, and it marks the 2 year anniversary of the 340B Unscripted Podcast. To mark the occasion, Greg asks Rob a hodgepodge of 340B-related questions including entity-owned vs contract pharmacy considerations, out-of-state Medicaid carve-out challenges, “class of trade”, referral capture documentation standards and how CEs should keep an eye on their OPAIS registration. Thanks everyone for listening, and here’s to another 50 episodes!
2024-08-0746 min340B UnscriptedEp 49 | HRSA Audit Trends and Manufacturer Audit Activity – Conversation with Emily CookIn this episode, Greg and Rob have another repeat guest! Healthcare attorney Emily Cook shares some insights gained from the 340B Coalition Summer Conference around recent HRSA audit patterns (08:37) and a cluster of manufacturer audits of 340B covered entities (27:46).
In the intro, the guys touch base on some 340B newsworthy developments in the contract pharmacy and legislative space.
Email us your 340B-related questions at 340BUnscripted@spendmend.com
2024-07-221h 05340B UnscriptedEp 48 | 2024 Midyear 340B Review - Conversation with Ted SlafskyIn this episode, Greg and Rob gear up for the 340B Summer Coalition conference, and are joined again by Ted Slafsky to discuss various 340B developments from the first half of 2024. They’ll discuss the ongoing contract pharmacy saga between entities and manufacturers, debate the future of proposed federal legislation addressing 340B Program reform, and recap pertinent court cases with both direct and indirect impact on 340B.
In the intro, the guys catch up on updated contract pharmacy restrictions and recent audit experiences.
Come find us at Booth #717 at the 2024 340B Coalition Summer Conference!
...
2024-07-071h 14340B UnscriptedEp 47 | Alternate Distribution Models & 340BIn this episode, Greg and Rob are joined by a new SpendMend team member – Nick Gnadt – to discuss considerations around the use of alternate distribution models (ADMs) in the 340B space. They discuss some of the practical considerations around implementing ADM, where there may be operational or regulatory challenges, and what the long-term outlook is for this more novel strategy.
In the intro, the guys recap a flurry of updates in contract pharmacy restrictions, and discuss a communication posted on OPA’s website that foreshadows what might be an increasing number of HRSA audit reports released over the ne...
2024-06-1755 min340B UnscriptedEp 46 | Revisiting the Intersection of the IRA Medicare Drug Pricing Program & 340B – Conversation with Jeff DavisIn this episode, Greg and Rob welcome back health care attorney Jeff Davis to catch up on the latest draft guidance published by CMS to address IRA-mandated Medicare drug pricing provisions and impact to 340B providers (15:25). Additionally, they chat about the 340B ACCESS Act, a new piece of draft legislation introduced in the House with sweeping 340B Program reform considerations (41:28).
In the intro, the guys talk about the Congressional developments around legislation and an upcoming House Energy & Commerce subcommittee hearing called on the 340B Program, recap the D.C. Circuit Court of Appeals ruling related to manufacturer-implemented contract p...
2024-06-0353 min340B UnscriptedEp 45 | Chevron Doctrine & 340BIn this episode, Greg and Rob are joined by healthcare attorney Ross Marguiles to discuss how a Supreme Court ruling on litigation in the fishing industry could have a major impact on the healthcare landscape. Ross provides background on Chevron deference, a 40-year judicial doctrine that allows courts to defer ruling to federal administrative agencies, and ponders what the ripple effects could be to the 340B community if SCOTUS overturns this long-standing rule.
In the intro, the guys catch up on state-level contract pharmacy legislation and share thoughts on some recent data published around the 340B Program.
2024-05-2254 min340B UnscriptedEp 44 | Pharmacotherapy Clinic Services & 340BIn this episode, SpendMend colleague Matt Parker joins Greg and Rob (14:00) to discuss pharmacotherapy services, and how pharmacist-driven care can help promote improved health outcomes in a community, as well as how these services might intersect with a covered entity’s 340B Program. They highlight the clinical and financial benefits that these services can provide, map out a typical workflow for how these services might be executed, and share thoughts on both operational and regulatory challenges that might be encountered when getting started.
In the intro, Rob and Greg briefly discuss some 340B news, including the recently pu...
2024-05-0653 min340B UnscriptedEp 43 | Getting to Know the HRSA DRL – DRL 8 Self-Disclosure Documentation and DRL 9 Medicaid Billing InformationIn this episode, Greg and Rob continue to provide insights on the HRSA data request list. DRL #8 is self-disclosure documentation and DRL #9 is Medicaid billing information, which includes providing details regarding your CE’s listing on the Medicaid Exclusion File, as well as sample billing claim forms for physician-administered drugs and billing claim screenshots for retail dispenses.
In the intro, they recap state-level 340B legislation, discuss ongoing uncertainty around Medicare Advantage & Part B underpayment remedies, and also note some recent data published on drug shortages.
Rob and other folks from our team will be attending Asem...
2024-04-2251 min
Leaders In TechPassion-Driven Pursuits: Creating Lasting Impact in HealthcareAs the Chief Technology Officer (CTO) at SpendMend, Jeremy Toth is spearheading a transformative mission to revolutionize healthcare affordability. With a steadfast commitment to reducing the financial strain of healthcare, Jeremy and his team are actively reshaping the landscape of healthcare expenditure. Their core objective is crystal clear: to diminish the financial burden on patients by implementing innovative cost-saving strategies and fostering financial responsibility. Jeremy firmly believes that these efforts should translate into tangible benefits for consumers, ensuring that advancements in healthcare affordability are accessible to all. Their journey towards this noble goal is marked by innovation, particularly in...
2024-04-1946 min340B UnscriptedEp 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 2SpendMend colleagues Jasmine and Megan continue their conversation providing some grantee CE perspectives concerning the HRSA DRL.
2024-04-1544 min340B UnscriptedEp 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1In this episode, SpendMend colleagues Jasmine and Megan provide some grantee CE perspectives concerning the HRSA DRL. They have so much great insight, we are breaking this conversation up into two parts. Stay tuned for Part 2 next week!
In the intro, Rob and Greg discuss thoughts around responding to manufacturer 340B inquiries.
2024-04-0848 min
Ripple of ChangeFive Minutes to Fix OUR Broken Healthcare System?Dr. Todd Otten, Jim Cagliostro, and Eva Minkoff discuss the importance of relationships and human connection in healthcare. Key Topics Discussed:The importance of relationships and human connection in healthcareHow relationships and human connection can improve patient outcomes and provider satisfactionThe role of patients and providers in fostering relationships and human connectionThe benefits of relationships and human connection for both patients and providersEpisode Links:VIE Healthcare, a SpendMend Company (more info: https://spendmend.com) https://Patientproviderconnection.comThanks for listening! To get your copy of Ripple of Change, please visit...
2024-03-2639 min340B UnscriptedEp 41 | 340B News & NotesIn this episode, Rob and Greg catch up on a cluster of developments in the 340B space, including updates to manufacturer contract pharmacy restrictions, thoughts on a federal appellate court ruling on Arkansas' contract pharmacy law, a preliminary take on the 340B PATIENTS Act recently introduced by Rep. Doris Matsui (D-CA), and an update on ongoing litigation between hospitals and HRSA over child site eligibility guidance.
Email us at 340BUnscripted@spendmend.com with comments, questions, or topic suggestions!
2024-03-2529 min340B UnscriptedEp 40 | Getting to Know the HRSA DRL: DRL 5 Purchasing Documentation and DRL 7 Entity-Owned Pharmacy DocumentationIn this episode, Greg and Rob continue reviewing data solicited by HRSA during an audit. DRL #5 is purchasing documentation, including a list of accounts, sample invoices, and 340B purchase order details. This ends up being a labor-intensive section to complete for HRSA, especially for larger organizations with a variety of purchasing practices. DRL #7 is an entity-owned pharmacy documentation, which includes demonstrating ownership of pharmacies that are dispensing 340B drugs but are not registered as contract pharmacies.
In the intro, the guys catch up on new manufacturer restrictions in the contract pharmacy space and share thoughts on other...
2024-03-1148 min
The Healthcare Leadership ExperienceData and Research in Healthcare Analytics | E. 1032024 has been described as a financial ''make or break'' year in healthcare. SpendMend Research Supervisor Zachary Markham explains to Jim Cagliostro why time and data are money for hospitals. Episode Introduction Zach explains why the lack of timely, accurate data can delay recovery of credits, and why most hospitals only have 50% visibility into their spend and accounts payable processes. He also shares why duplicate payments and credit on spend are the top two methods for recovery of costs, and highlights how uncovering dark data saved SpendMend clients $413 million in 2023. ...
2024-02-2823 min340B UnscriptedEp 39 | A Revisit of Ongoing Contract Pharmacy RestrictionsIn this episode, Greg and Rob are once again joined by SpendMend team member Riley Protz, to catch up on the current state of ongoing manufacturer restrictions on 340B contract pharmacy operations, as well as to offer insights on various mitigation strategies, like the opportunity for grantee CEs to make associated site contract pharmacy designations in 340B ESP.
If you have questions about this topic or have other topics that you want us to address on the podcast, email us at 340BUnscripted@spendmend.com.
Pharmacy technicians and Pharmacists looking for CE credits? Please register to a...
2024-02-2632 min340B UnscriptedEp 38 | Getting to Know the HRSA DRL: DRL 4 Provider List and DRL 6 Contract Pharmacy DocumentationIn this episode, Greg and Rob continue their review of items from the HRSA audit data request list (DRL). They’ll cover DRL #4, the provider list, as well as DRL #6, contract pharmacy documentation. Don’t worry – they’ll come back to DRL #5 (purchasing documentation) in an upcoming episode!
In the intro, Rob shares a few insights from the recent 340B Coalition Winter Meeting in San Diego, and then the guys catch up on some 340B related news. They’ll share a quick reminder on grantee 340B annual recertification (starting now through 2/26/2024) and describe communication HRSA has been send...
2024-02-121h 04340B UnscriptedEp 37 | Getting to Know HRSA DRL: Part 3 - 340B Universe DataIn this episode, Greg and Rob continue to cover the HRSA data request list, focusing this week on DRL item #3, probably the most complex of all of the sections – 340B universe data. They’ll talk about tips for organizing your 340B utilization data for an HRSA audit, and share insights regarding what the HRSA audit experience might be like when reviewing this data.
In the intro, the guys catch up on state-level 340B legislative updates, discuss CMS’s upcoming process for Medicare Part B repayments, and talk about a new Medicaid rebate policy change that might impact 340B prov...
2024-01-291h 06The Healthcare Leadership Experience$1 Billion in Hospital Financial Improvements | E. 98A focus on frontline innovation has kept VIE Healthcare at the forefront of hospital cost savings for 25 years. Lisa Miller shares her formula for success with Jim Cagliostro. Episode Introduction Lisa outlines how getting to the line-item details in purchased services was the key to early success, the 'what-if' questions that led to patents, and why hospitals should never settle for 10% in savings when digging deeper might lead to 25%. She also explains why letting the data speak takes the emotion out of vendor meetings, and why hospitals need to work with companies that...
2024-01-2430 min340B UnscriptedEp 36 | Getting to Know HRSA DRL: Part 2 - CE Eligibility DocumentationIn Episode 36, Greg and Rob provide updates on recent 340B news around state legislation, manufacturer restrictions, and HRSA's decision to not appeal the Genesis case court ruling. They also provide insight and thoughts around the HRSA data request list item 2, the covered entity eligibility documentation.
Also, if you are at 340B Winter Coalition, make sure to come see the team at Booth 611.
2024-01-1543 minThe Healthcare Leadership ExperienceWhy Hospital Profit Recovery Audits Are So Important | E. 95As hospitals continue to face rising costs in 2024, David Hewitt, Snr VP of Sales at SpendMend, highlights the importance of recovery audits, and the SpendMend difference, with Managing Director Lisa Miller. Episode Introduction David explains why SpendMend carries out audits every 90 days, and how the company's deep expertise delivers results within three weeks. He also outlines the importance of recognizing patterns and trends in data, how a snow accumulator saved tens of thousands of dollars for one hospital, and why every CFO should care about recovery audits. Show Topics
2024-01-0533 min340B UnscriptedEp 35 | Top 10 Developments in 340B for 2023For our last episode of 2023, Greg and Rob reviewed hot topics impacting 340B covered entities from the past year.
2023-12-181h 05340B UnscriptedEp 34 | Maintaining 340B Compliance: The Importance of Self-AuditingIn this episode, Greg and Rob are joined by Spendmend colleague Cat Eriksen (16:11) to discuss the importance of self-auditing as part of a 340B covered entity’s overall compliance strategy. They’ll talk about HRSA standards around self-auditing, how some hospitals and clinics struggle to prioritize this effort, and why seeking external support to address self-auditing needs might be a good approach for some.
But first, the guys share additional thoughts on the recent Genesis case.
SpendMend is at ASHP Midyear, stop by and see some members of our team at Booth 1500.
Also, don’...
2023-12-0444 min340B UnscriptedEp 33 | Thoughts on the Genesis v. Becerra Court RulingIn this episode, Rob and Greg share thoughts from the recent federal court ruling on the Genesis v Becerra case, which focuses on patient definition. Additionally, they catch up on manufacturer restriction changes and some developments from recent Senate HELP Committee 340B inquiries.
If you are attending the ASHP Clinical Midyear meeting in Anaheim, make sure to stop by booth 1500 to see us!
2023-11-2038 min340B UnscriptedEp 32 | Getting to Know the HRSA DRL: Part 1 – Policies & ProceduresThis episode is the first part of a series of recordings we are putting together to review the HRSA data request list (DRL). Rob and Greg discuss DRL item #1 – 340B Policies and Procedures. They’ll review the types of operations that HRSA expects to see outlined in a covered entity’s 340B policies and share some insights into how to manage these documents.
HRSA audit readiness and a detailed overview of the DRL will be the subject of our next SpendMend Pharmacy Webinar in December 2023. Look for more information on registering for this webinar on our social media pa...
2023-11-0658 min340B UnscriptedBonus Ep 2 | HRSA Notice Addressing 340B Registration RequirementsIn this bonus episode, Rob and Greg review the HRSA notice published on October 27 that addresses the immediate use of 340B drugs in unregistered locations and some hospital considerations in response to the update.
2023-10-2724 min340B UnscriptedEp 31 | Answering 340B FAQs - Rob vs. ChatGPTIn this episode, Rob is pitted against ChatGPT to answer 340B-related FAQs, including topics like child site registration, GPO prohibition, and HRSA audit findings (17:29). In the intro, Greg and Rob catch up on revised contract pharmacy restrictions and thoughts on recent manufacturer inquiries that 340B entities have been receiving.
Email us questions, comments, or suggested podcast topics at 340BUnscripted@spendmend.com!
2023-10-231h 02The Healthcare Leadership ExperienceRebate Management in Healthcare | E. 90Hospitals are under continued pressure to reduce costs and deliver better care. CoFounders of Rebate Insight, Tony Garcia and Jonas Langvad, explain the benefits of rebate management to Jim Cagliostro. Episode Introduction Tony & Jonas explain why 100% of rebates go straight to the bottom line, share the 3 Ms of rebate management, and highlight how Rebate Insight's SaaS solution is increasing hospital rebates by 26% or more. They also explain how ''dark data'' blurs visibility into rebate management and celebrate being part of SpendMend. Show Topics ...
2023-10-1822 min340B UnscriptedEp 30 | Turnkey Pharmacy Solutions, Whiteboards & 340B StuffRich Bucher, one of the co-founders of Turnkey Pharmacy Solutions, makes a long-awaited appearance on the podcast with Greg and Rob. Rich and Rob share anecdotes from their early days getting involved in external 340B support (23:26). Rich also shares some thoughts on 340B topics like GPO Prohibition mitigation strategies (39:13), what to make of the FAQ 4301 developments earlier this year (49:58) and opinions on recent state-enacted laws addressing contract pharmacy provisions (57:49).
In the intro, Greg, Rob, and Rich get caught up on manufacturer restrictions and react to inquiries sent to 340B hospitals from the Senate HELP Committee.
2023-10-091h 07340B UnscriptedEp 29 | The Intersection Between the Inflation Reduction Act (IRA) & 340B – Conversation with Jeff DavisIn this episode, Greg and Rob are joined by healthcare attorney Jeff Davis, to discuss how the Medicare drug pricing provisions in the IRA will impact 340B providers. They’ll go over CMS billing modifier requirements (15:27), share opinions on the financial impact covered entities might experience (38:02), and how various legal challenges to the IRA by the pharma industry may play out (56:29). They also add some insights around CMS’s proposed Part B payment remedy (1:01:03).
In the intro, Rob catches Greg up on new manufacturer restrictions, and some recent HRSA audit experience related to interpreting data request list (DRL) r...
2023-09-251h 09340B UnscriptedEp 28 | 340B Conversation with Emily Cook - Part 2Rob and Greg continue their conversation with health care attorney and 340B expert Emily Cook (21:05). They discuss thoughts on the CMS Medicare Part B remedy, provide some commentary on the Inflation Reduction Act (IRA) and its intersection with 340B covered entities, and address an issue that could impact hospital DSH eligibility in the future.
In the intro, Greg and Rob are joined by SpendMend colleague Jennifer Hagen and catch up on recent 340B developments, including updates on manufacturer restrictions, follow-up from a prior question about CAR-T therapy, as well as Spendmend’s reference within an amicus brief fil...
2023-09-1150 min340B UnscriptedEp 27 | 340B Conversation with Emily Cook - Part 1Rob and Greg are joined by Emily Cook (20:15), an attorney in the health care and 340B space. They discuss a number of 340B topics, including ongoing manufacturer restrictions of contract pharmacies (24:52) as well as legal challenges to HRSA’s patient definition (42:16). This is part one of a two-part series, so look for a future podcast episode with more conversation among Rob, Greg, and Emily.
In the intro, the guys catch up on some news and noteworthy 340B items, including drug shortage legislation, state-level 340B developments, tips on addressing manufacturer repayment notifications, and reminders about hospital-CE recertification.
2023-08-281h 08340B UnscriptedEp 26 | First Year Anniversary of the 340B Unscripted Podcast - Q & A SessionAiden shares the 340B questions sent in by our listeners, and there are some good ones. Questions include opening an in-house retail pharmacy, CAR-T therapy, continuum of care and 190 clinics, the IRA, and a couple of other fun ones.
On our one-year anniversary, we want to thank everyone for listening and for all the encouragement we have received.
2023-08-141h 05340B UnscriptedEp 25 | 340B Coalition Summer Conference Recap - Part 2Rob and Greg continue to unpack all the great information gathered from the 2023 340B Coalition Summer Conference in Washington D.C. They chat with coworkers, clients, and friends in the 340B community to share insights from sessions at the Conference. Guests include SpendMend colleagues Jennifer Hagen (16:54) and Shakita Carter (38:12), as well as 340B hospital experts Erin Leigh (47:12), Nan Kempadoo (1:00:14) and Pooja Shah (1:14:08).
Submit your questions for Rob and Greg here: https://ww2.spendmend.com/340b-unscripted-qa/
2023-07-311h 33340B UnscriptedEp 24 | 340B Coalition Summer Conference RecapGreg and Rob share highlights from the 340B Coalition Conference in DC. Topics covered include proposed CMS repayment for affected hospitals, Inflation Reduction Act updates, legislative updates, and other worthy conference discussions.
2023-07-1754 min340B UnscriptedEp 23 | 340B and the Medicare Cost ReportGreg and Rob break down the ins and outs of the Medicare Cost Report and the dos and don'ts of child site registrations. They also provide an update on contract pharmacy manufacturer restrictions and information on the upcoming 340B Coalition Conference. We also hear from our Producer Aiden and provide the secret password for your free 340B Unscripted t-shirt at the conference.
2023-07-0357 min340B UnscriptedEp 22 | Maintaining 340B Compliance: Medicaid Duplicate Discount PreventionIn this episode, Greg and Rob talk about an important 340B Program compliance element – preventing Medicaid duplicate discounts. They discuss the importance of maintaining the Medicaid Exclusion File (MEF), challenges with managing state-specific billing requirements, and strategies for managing out-of-state Medicaid.
In the intro, the guys review updates to manufacturer restrictions for contract pharmacies and share anecdotes from recent HRSA audit experiences.
2023-06-191h 04340B UnscriptedEp 21 | Thoughts on 340B & Biosimilar UptakeIn this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
2023-06-0540 min340B UnscriptedEp 20 | 340B History Lesson – The Morford LetterIn this episode, Rob and Greg discuss an interesting piece of 340B history – the Morford letter (25:31). Rob shares his understanding of the origins of the letter and contemporary application of the letter as it relates to the recent debate around the 340B-eligible patient definition.
But first, the guys catch up on 340B news, including:
-A reminder of 340B protections offered under the 2022 Consolidated Appropriations Act (i.e., DSH attestation)
-Legislative updates from the House E&C health subcommittee bill mark-up session
-Updated manufacturer restrictions for contract pharmacies
To access a copy...
2023-05-2254 min340B UnscriptedBonus Ep 1 | New 340B Location Qualification and FAQ 4301 UpdateGreg and Rob provide a quick update on FAQ 4301 and where we are with HRSA removing language around the immediate use of new 340B locations.
2023-05-1516 min2023-05-0803 min340B UnscriptedEp 19 | 340B D.C. Update – Conversation with Ted SlafskyIn this episode, Rob and Greg are joined by guest Ted Slafsky, of 340B Report and Wexford Solutions (13:20). Ted shares his thoughts on the ongoing contract pharmacy impasse, updates on legislative developments coming out of D.C., and highlights some of the emerging advocacy groups as the debate over 340B Program reform heats up.
But first, Greg and Rob discuss upcoming recertification for grantee-covered entities and debate what the end of the COVID-19 Public Health Emergency means for 340B covered entities.
2023-05-081h 09340B UnscriptedEp 18 | 340B Program Reform – A Conversation with NACHCThis week, Rob and Greg connected with Vacheria Keys, Director of Policy & Regulatory Affairs at NACHC. Vacheria will talk about her role at NACHC and how the health centers she represents have been impacted by a number of ongoing 340B developments (23:05). She’ll also share her thoughts on where things may go in terms of ongoing litigation related to contract pharmacy restrictions and patient definition (30:29). Finally, Vacheria and the guys will chat about NACHC’s 340B advocacy efforts, specifically the recently unveiled ASAP 340B policy principles (39:48).
In the intro, the guys follow up on some earlier discussions regard...
2023-04-241h 11340B UnscriptedEp 17 | 2023 Winter Coalition Recap and More!Rob is back from San Diego, and he and Greg have a lot to catch up on, including a recap of notable events and sessions from the 340B Coalition 2023 Winter Conference (27:37). But first, They’ll discuss recent changes to manufacturer-related contract pharmacy restrictions (1:03), share insights from recent Congressional hearings where 340B has been a focus (13:42), discuss recent OPAIS changes (20:43) and talk about the impact hospitals might expect with the phase-out of continuous Medicaid coverage starting this month (24:03).
Stick around at the end to catch sound bytes from SpendMend staff on what they learned at the Coalition conference!
2023-04-101h 03340B UnscriptedEp 16 | Dissecting Recent 340B Program Reform ProposalsIn this episode, Rob and Greg dissect some of the finer details of the ASAP 340B policy principles. They’ll address the merits of proposed reform around topics like patient definition, hospital and child site eligibility, contract pharmacy provisions, and 340B savings transparency, among other targeted policy areas. Also, with the 340B Coalition Winter Conference right around the corner, the guys highlight sessions and presentations (41:08) featuring SpendMend clients and 340B friends that you won’t want to miss. The SpendMend Pharmacy team will be at Booth 319, so if you attend the Coalition, make sure to stop by. And no worrie...
2023-03-2744 min340B UnscriptedEp 15 | Building Your 340B TeamIn this episode, Rob and Greg are joined by pharmacist leader and 340B expert Leah Marcelin (22:32) to share thoughts and ideas about building out an expert staff to manage your 340B program. They’ll debate strategies for right-sizing and organizing your team, share tips on recruiting 340B talent, and offer ideas on how to provide training and enrichment to 340B team staff members.
But first, Rob and Greg spend some time discussing a new organization - ASAP 340B, and their advocacy campaign proposing several reforms to the 340B Program. They’ll give a run-down of each of the...
2023-03-131h 05340B UnscriptedEp 14 | All About 340B Grantees (Part 2)This is part two of our two-part series focusing on 340B grantee-covered entities. The team talks about the importance of maintaining auditable records (15:34) and the challenges that many grantees face in meeting this 340B eligibility requirement. Also, they cover important billing considerations related to Medicaid Duplicate Discount prevention (31:20). Finally, the group debates future developments that 340B grantee-covered entities should keep on their radar through 2023 (45:52).
But first, Greg and Rob catch up on 340B implications from the Consolidated Appropriations Act of 2023 and share insights from a recent publication (J Manag Care Spec Pharm. 2023;29(3):229-35) that predicts which drugs...
2023-03-061h 00340B UnscriptedEp 14 | All About 340B Grantees (Part 1)This episode is the first part of a two-part series focusing on 340B grantee-covered entities. Rob and Greg are joined by SpendMend pharmacy experts (19:43) who bring their FQHC and Ryan White experience to share insights into 340B Program participation from the grantee perspective. They’ll discuss what to look out for regarding OPAIS registrations (21:00) and requirements for using 340B savings (33:11).
But first, Rob and Greg catch up on the latest 340B developments, including new J&J contract pharmacy restrictions and a recent publication that reviews implications around new CMS billing modifier requirements for IRA-mandated inflation rebate penalties.
2023-02-2738 min340B UnscriptedEp 13 | Update on Manufacturer Restrictions for 340B Contract PharmaciesIn this episode, Rob and Greg catch up on recent 340B developments, including the 3rd Circuit Court ruling on one of the contract pharmacy cases and the subsequent changes to some manufacturer's policies (1:36), how the new shape of the Senate HELP Committee may influence 340B legislative debate, and why a renewed focus on advocacy might be helpful (9:39) and what the end of the COVID-19 Public Health Emergency (PHE) might mean for 340B Program operations (15:54).
Later, Rob and Greg are joined by colleague Riley Protz (25:24), and they discuss the latest challenges with manufacturer restrictions in the 340B contract...
2023-02-131h 04340B UnscriptedEp 12 | Pharmacy Benefit Optimization for 340B Covered EntitiesRob and Greg kick off the episode with some discussion around news and noteworthy items across the 340B landscape, including more dialogue around CMS guidance on “JG”/”TB” modifiers (1:01), 340B in the news media (4:31), grantee recertification tips (14:13) and ongoing challenges working 340B ESP (18:39). Later in the episode, they are joined by Victoria Ferris of OptumRx and Thatcher Sloan of RxBenefits to discuss pharmacy benefit strategy as an underappreciated opportunity in the 340B space (26:23).
2023-01-3053 min2023-01-1632 minThe Healthcare Leadership ExperienceWhy Communication Matters with Brian Morgan | E. 58Explore the impact of the written word and what it means for healthcare. Episode Introduction In this episode, Lisa Miller, Managing Director at SpendMend, interviewed Brian Morgan to learn more about the principles and mission of Think Deeply, Write Clearly. Topics include the impact of language and communication on business credibility, why comprehension of the written word belongs only to the reader, how better communication could improve healthcare, and why innovation isn't always exclusively about technology. Show Topics Why we're good at...
2023-01-0644 min340B UnscriptedEp 10 | Top 10 Developments in 340B for 2022For our last episode of 2022 Rob and Greg are joined again by SpendMend colleague Matt Parker and debate the top developments in the 340B space over the last year.
2022-12-1247 min340B UnscriptedEp 9 | TPA Transition Tips and TricksIn this episode, we have podcast guests Anna Bulochnik, and Chelsea Violette to discuss the challenging task of switching third-party administrators (TPAs). Great tips and recommendations on how to make the transition as smooth as possible.
2022-11-2849 min340B UnscriptedEp 8 | Trulla - Modernizing Pharmacy ProcurementOn this episode, Rob and Greg welcome a few new SpendMend colleagues - Curtis McEntire and Angela Whitney– to talk about Trulla, a state-of-the-art pharmacy procurement solution now offered by SpendMend. They’ll talk about the challenges of today’s pharmacy buyer, common untapped opportunities for drug savings, and how Trulla can bring your pharmacy procurement process into the future.
2022-11-1444 min340B UnscriptedEp 7 | Don’t be Haunted by a HRSA Audit!It’s Halloween, and in this episode, Greg and Rob invite guests from the field to discuss “tricks and treats” from recent HRSA audit experiences! They’ll review strategies for gathering audit data, the coaching staff for the onsite visit, and what you need to consider when you eventually receive your final audit report. HRSA audits can be a “frightening” experience, but this conversation will give you lots of info to help you be ready! Also, the guys share updates on CMS OPPS payments for 340B hospitals.
2022-10-311h 16The Healthcare Leadership ExperienceMedical Device Warranty Credits With Al Brander| E. 55How SpendMend's Explanted Medical Device Warranty Credit Tracking solution helps hospitals to avoid costly fees and penalties. Episode Introduction In this episode, Lisa Miller, founder of VIE Healthcare and CEO of Spendmend ,and Jim Cagliostro, VIE's Clinical Operations Performance Improvement Expert, interviewed Al Brander to explore in detail the challenges and financial risks of managing medical device warranties. Topics include the risk of ''Medicare fraud'', how hospitals are throwing away cash, why financial and legal responsibility lies with the explanting hospital, and a detailed presentation on the compliance and revenue benefits...
2022-10-2839 min340B UnscriptedEp 6 | 340B NYT Article: Are You Next?In this episode, Rob and Gren welcome William Mayhood to the Pod and get into the New York Times article on Bon Secours’ 340B program. We shift gears and get into what covered entities should be doing in preparation for a similar media article, or congressional inquiry, and bring back the 340B Impact Statement. You never know, your CE could be next!
2022-10-1739 min340B UnscriptedEp 5 | Weighing the Risk: Referral Capture vs. Continuum of CareIn this episode, Greg and Rob are joined by another SpendMend Pharmacy colleague – Riley Protz, who serves as Director of Optimization. They discuss the impact of referral capture opportunities on 340B Program participation and debate the risks of this strategy in comparison with other strategies, like the application of the “continuum of care” in the patient definition.
2022-10-0342 min340B UnscriptedEp 4 | Inflation Reduction Act’s 340B ImpactIn Episode 4 of the 340B Unscripted podcast, Greg and Rob bring on Matt Parker, VP of Optimization and Growth at SpendMend AND the maestro behind the scenes of the podcast, to discuss the Inflation Reduction Act and how it impacts 340B. We discuss both the inflation penalty impact starting in 2023 and the negotiated Medicare pricing impact that starts in 2026.
2022-09-1941 min340B UnscriptedEp 3 | Future Outlook of 340B Contract Pharmacy Limitations In this episode, Greg and Rob are joined by SpendMend colleague Jacob Thompson to discuss the future outlook of the 340B Contract Pharmacy Limitations. They review past 340B/CMS litigation that ultimately ended at the Supreme Court. From that review, they predict the path and length of time these limitations are most likely in place. This is a very important topic as CEs navigate if they should submit data to 340B ESP.
2022-09-0522 min340B UnscriptedEp 2 | 2022 340B Coalition Summer RecapIn this episode, Greg and Rob are back from Washington, D.C., and are joined by SpendMend colleague Jennifer Hagen to recap highlights from the 2022 Summer 340B Coalition Conference. They dig into lessons learned from various sessions at the conference and chat about HRSA audit trends, operational challenges from recent manufacturer restrictions, as well as “big picture” considerations for 340B covered entities for the remainder of 2022. Also, stick around at the end of the episode to hear sound bytes from SpendMend staff, clients, and friends who gathered together at the conference!
2022-08-221h 002022-08-011h 082022-07-1202 minThe Healthcare Leadership ExperienceZero-Based Budgeting With Lisa Larter | E. 41 Why making the mindset shift to zero-based budgeting can lead to substantial cost savings for your hospital. Episode Introduction In Episode 41 of The Healthcare Leadership Experience, Lisa is joined by her show producer Lisa Larter. Together they discuss zero-based budgeting for hospitals. As Lisa Miller comments, ''Sometimes it's not about pricing. Sometimes it's not about consolidation. Sometimes it's going through your hospital's budget…department by department. Test it out, ask some questions. It's definitely a different approach from traditional budgeting. It's very precise.'' This epis...
2022-04-0826 min
The HELLO World PodcastEpisode 08: "E" - Growth Strategies: How to Get and Keep Your Clients with Tom FlynnTom Flynn currently serves as the VP of Marketing for SpendMend; the host of his "TMI Podcast"; and the Founder and Managing Director of Izaros Consulting.
In his career, Tom has founded multiple technology firms selling two of his companies in the past five years.
In 2020, Tom earned his sixth straight Pro-to-Know designation by SDCExec.
In 2016, he was recognized as a Top Tech CMO in California by TMT and honored as the country's Top Marketing Executive for companies with 11-99 employees by SVUS.
Tom was also selected in the 2016 "Silicon Valley 50"...
2020-08-2551 min